Related references
Note: Only part of the references are listed.Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis
Jelger Louwsma et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2021)
A multicentre validation study of the diagnostic value of plasma neurofilament light
Nicholas J. Ashton et al.
Nature Communications (2021)
CHIT1 at Diagnosis Reflects Long-Term Multiple Sclerosis Disease Activity
Emanuela Oldoni et al.
ANNALS OF NEUROLOGY (2020)
Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion
Joke De Vocht et al.
JAMA NEUROLOGY (2020)
PET imaging shows no changes in TSPO brain density after IFN-α immune challenge in healthy human volunteers
M. A. Nettis et al.
TRANSLATIONAL PSYCHIATRY (2020)
PET imaging of neuroinflammation in neurological disorders
William C. Kreisl et al.
LANCET NEUROLOGY (2020)
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Bruno Lima Giacobbo et al.
MOLECULAR NEUROBIOLOGY (2019)
The association of psychosocial risk factors for mental health with a brain marker altered by inflammation: A translocator protein (TSPO) PET imaging study
Tarik Dahoun et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Genetic Modulation of Neurocognitive Development in Cancer Patients throughout the Lifespan: a Systematic Review
Charlotte Sleurs et al.
NEUROPSYCHOLOGY REVIEW (2019)
Age-dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients
Jeroen Blommaert et al.
HUMAN BRAIN MAPPING (2019)
MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation
J-Donald Tournier et al.
NEUROIMAGE (2019)
Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment
Erin M. Gibson et al.
CELL (2019)
Diagnostic and Prognostic Performance of Neurofilaments in ALS
Koen Poesen et al.
FRONTIERS IN NEUROLOGY (2019)
Regional Accuracy of ZTE-Based Attenuation Correction in Static [18F]FDG and Dynamic [18F]PE2I Brain PET/MR
Georg Schramm et al.
FRONTIERS IN PHYSICS (2019)
A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer
Janette L. Vardy et al.
BRAIN IMAGING AND BEHAVIOR (2019)
Increased Expression of Translocator Protein (TSPO) Marks Pro-inflammatory Microglia but Does Not Predict Neurodegeneration
Lien Beckers et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry
T. Notter et al.
MOLECULAR PSYCHIATRY (2018)
Cognitive Effects of Cancer and Cancer Treatments
Tim A. Ahles et al.
Annual Review of Clinical Psychology (2018)
Chemotherapy and cognition: International cognition and cancer task force recommendations for harmonising preclinical research
Gordon Winocur et al.
CANCER TREATMENT REVIEWS (2018)
Advanced MR diffusion imaging and chemotherapy-related changes in cerebral white matter microstructure of survivors of childhood bone and soft tissue sarcoma?
Charlotte Sleurs et al.
HUMAN BRAIN MAPPING (2018)
Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
Asa Sandelius et al.
NEUROLOGY (2018)
Neurobiological Mechanisms of Chemotherapy-induced Cognitive Impairment in a Transgenic Model of Breast Cancer
Gordon Winocur et al.
NEUROSCIENCE (2018)
Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic review
Mingmei Li et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Neuroimmunology of Behavioral Comorbidities Associated with Cancer and Cancer Treatments
Jessica C. Santos et al.
FRONTIERS IN IMMUNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study
Kimberly D. van der Willik et al.
BREAST CANCER RESEARCH (2018)
Chronic Treatment with Combined Chemotherapeutic Agents Affects Hippocampal Micromorphometry and Function in Mice, Independently of Neuroinflammation
Sohi Kang et al.
EXPERIMENTAL NEUROBIOLOGY (2018)
Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study
Sanne Menning et al.
BRAIN IMAGING AND BEHAVIOR (2018)
Cognitive function following breast cancer treatment and associations with concurrent symptoms
Kathleen Van Dyk et al.
NPJ BREAST CANCER (2018)
Effect of anti-cancer drugs on microglia in patient-derived breast cancer xenografted mouse models
Claire Paquet et al.
NEUROPATHOLOGY (2017)
Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans
David R. Owen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Changes in Brain Structural Networks and Cognitive Functions in Testicular Cancer Patients Receiving Cisplatin-Based Chemotherapy
Ali Amidi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Investigating white matter fibre density and morphology using fixel-based analysis
David A. Raffelt et al.
NEUROIMAGE (2017)
Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease
Koen Poesen et al.
NEUROLOGY (2017)
Changes in Brain Structural Networks and Cognitive Functions in Testicular Cancer Patients Receiving Cisplatin-Based Chemotherapy
Ali Amidi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Biomarkers Associated with Cognitive Impairment in Treated Cancer Patients: Potential Predisposition and Risk Factors
Hélène Castel et al.
Frontiers in Pharmacology (2017)
Neurobiological changes by cytotoxic agents in mice
R. Seigers et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction
Hannah R. Wardill et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The cellular composition of the human immune system is shaped by age and cohabitation
Edward J. Carr et al.
NATURE IMMUNOLOGY (2016)
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
Joakim Bergman et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Potential Role of pNF-H, a Biomarker of Axonal Damage in the Central Nervous System, as a Predictive Marker of Chemotherapy-Induced Cognitive Impairment
Akina Natori et al.
CLINICAL CANCER RESEARCH (2015)
The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases
Nidhi Garg et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Optimized Quantification of Translocator Protein Radioligand 18F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers
Sonia Lavisse et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Mechanisms of chemotherapy-induced behavioral toxicities
Elisabeth G. Vichaya et al.
FRONTIERS IN NEUROSCIENCE (2015)
Frontal hypometabolism in elderly breast cancer survivors determined by [18F] fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study
Laura L. Boles Ponto et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Dysregulation in myelination mediated by persistent neuroinflammation: Possible mechanisms in chemotherapy-related cognitive impairment
Teresita L. Briones et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Multi-tissue constrained spherical deconvolution for improved analysis of multi-shell diffusion MRI data
Ben Jeurissen et al.
NEUROIMAGE (2014)
Prevalence, mechanisms, and management of cancer-related cognitive impairment
Michelle C. Janelsins et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2014)
Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Patricia A. Ganz et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors
Shelli Kesler et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Chemotherapy-related cognitive dysfunction: current animal studies and future directions
R. Seigers et al.
BRAIN IMAGING AND BEHAVIOR (2013)
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Johanna Gaiottino et al.
PLOS ONE (2013)
Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy
Lori-Ann Christie et al.
CLINICAL CANCER RESEARCH (2012)
Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning
Sabine Deprez et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Reconciling subjective memory complaints with objective memory performance in the menopausal transition
Miriam T. Weber et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2012)
Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation
Nicolas Arlicot et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease
Benjamin A. Thomas et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Chemotherapy-Induced Structural Changes in Cerebral White Matter and its Correlation With Impaired Cognitive Functioning in Breast Cancer Patients
Sabine Deprez et al.
HUMAN BRAIN MAPPING (2011)
Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands
David R. J. Owen et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
Jeffrey S. Wefel et al.
LANCET ONCOLOGY (2011)
Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research
Riejanne Seigers et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release
Riejanne Seigers et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Cytokine levels in patients (pts) with colorectal cancer and breast cancer and their relationship to fatigue and cognitive function
J. L. Vardy et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Evaluation of cognitive function associated with chemotherapy: A review of published studies and recommendations for future research
Janette Vardy et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Candidate mechanisms for chemotherapy-induced cognitive changes
Tim A. Ahles et al.
NATURE REVIEWS CANCER (2007)
Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer:: 1-and 2-year follow-up of a prospective controlled study
HGM Fan et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection
CL Carey et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2004)
Examination of the dimensionality of fatigue - The Construction of the Fatigue Assessment Scale (FAS)
HJ Michielsen et al.
EUROPEAN JOURNAL OF PSYCHOLOGICAL ASSESSMENT (2004)
Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes
N Tsavaris et al.
BRITISH JOURNAL OF CANCER (2002)
Role of protein kinase C epsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat
OA Dina et al.
NEUROSCIENCE (2001)
Share Paper
